319 related articles for article (PubMed ID: 11550120)
41. NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis.
Denning DW; Lee JY; Hostetler JS; Pappas P; Kauffman CA; Dewsnup DH; Galgiani JN; Graybill JR; Sugar AM; Catanzaro A
Am J Med; 1994 Aug; 97(2):135-44. PubMed ID: 8059779
[TBL] [Abstract][Full Text] [Related]
42. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
Grigull L; Kuehlke O; Beilken A; Sander A; Linderkamp C; Schmid H; Seidemann K; Sykora KW; Schuster FR; Welte K
Pediatr Transplant; 2007 May; 11(3):261-6. PubMed ID: 17430480
[TBL] [Abstract][Full Text] [Related]
43. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
[TBL] [Abstract][Full Text] [Related]
44. Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients.
Chandrasekar PH; Ito JI
Clin Infect Dis; 2005 May; 40 Suppl 6():S392-400. PubMed ID: 15809925
[TBL] [Abstract][Full Text] [Related]
45. A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection.
Zhou H; Goldman M; Wu J; Woestenborghs R; Hassell AE; Lee P; Baruch A; Pesco-Koplowitz L; Borum J; Wheat LJ
J Clin Pharmacol; 1998 Jul; 38(7):593-602. PubMed ID: 9702843
[TBL] [Abstract][Full Text] [Related]
46. The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis.
Jain LR; Denning DW
J Infect; 2006 May; 52(5):e133-7. PubMed ID: 16427702
[TBL] [Abstract][Full Text] [Related]
47. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
[TBL] [Abstract][Full Text] [Related]
48. An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis.
Queiroz-Telles F; Goldani LZ; Schlamm HT; Goodrich JM; Espinel-Ingroff A; Shikanai-Yasuda MA
Clin Infect Dis; 2007 Dec; 45(11):1462-9. PubMed ID: 17990229
[TBL] [Abstract][Full Text] [Related]
49. [Long-term treatment of patients with itraconazole for the prevention of Aspergillus infections in patients with chronic granulomatous disease (CGD)].
Petropoulou T; Liese J; Tintelnot K; Gahr M; Belohradsky BH
Mycoses; 1994; 37 Suppl 2():64-9. PubMed ID: 7609746
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics of intravenous itraconazole followed by itraconazole oral solution in patients with human immunodeficiency virus infection.
Zhao Q; Zhou H; Pesco-Koplowitz L
J Clin Pharmacol; 2001 Dec; 41(12):1319-28. PubMed ID: 11762559
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis.
Gavaldà J; Martín T; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruiz I; Pahissa A
Clin Microbiol Infect; 2005 Dec; 11(12):999-1004. PubMed ID: 16307554
[TBL] [Abstract][Full Text] [Related]
52. [Improvement of patient adherence by mixing oral itraconazole solution with a beverage (orange juice)].
Adachi Y; Sumikuma T; Kagami R; Nishio A; Akasaka K; Tsunemine H; Kodaka T; Hiramatsu Y; Tada H
Rinsho Ketsueki; 2010 May; 51(5):315-9. PubMed ID: 20534951
[TBL] [Abstract][Full Text] [Related]
53. [Prevention of aspergillosis with itraconazole in neutropenic patients: importance of drug monitoring].
Cheymol G; Poirier JM
Bull Acad Natl Med; 1999; 183(2):371-80; discussion 380-1. PubMed ID: 10371783
[TBL] [Abstract][Full Text] [Related]
54. Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors.
Subirà M; Martino R; Franquet T; Puzo C; Altés A; Sureda A; Brunet S; Sierra J
Haematologica; 2002 May; 87(5):528-34. PubMed ID: 12010668
[TBL] [Abstract][Full Text] [Related]
55. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
Harousseau JL; Dekker AW; Stamatoullas-Bastard A; Fassas A; Linkesch W; Gouveia J; De Bock R; Rovira M; Seifert WF; Joosen H; Peeters M; De Beule K
Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349
[TBL] [Abstract][Full Text] [Related]
56. [Semi-invasive aspergillosis with involvement of the thoracic wall cured by itraconazole].
Milleron B; Roger V; Roux P; Lebreton C; Koeger A; Dupont B; Akoun G
Rev Pneumol Clin; 1990; 46(4):175-7. PubMed ID: 1966029
[TBL] [Abstract][Full Text] [Related]
57. A model for treating avian aspergillosis: serum and lung tissue kinetics for Japanese quail (Coturnix japonica) following single and multiple aerosol exposures of a nanoparticulate itraconazole suspension.
Rundfeldt C; Wyska E; Steckel H; Witkowski A; Jeżewska-Witkowska G; Wlaź P
Med Mycol; 2013 Nov; 51(8):800-10. PubMed ID: 23815436
[TBL] [Abstract][Full Text] [Related]
58. Marked intra- and inter-patient variability of itraconazole steady state plasma concentrations.
Poirier JM; Berlioz F; Isnard F; Cheymol G
Therapie; 1996; 51(2):163-7. PubMed ID: 8763051
[TBL] [Abstract][Full Text] [Related]
59. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases.
Mouas H; Lutsar I; Dupont B; Fain O; Herbrecht R; Lescure FX; Lortholary O;
Clin Infect Dis; 2005 Apr; 40(8):1141-7. PubMed ID: 15791514
[TBL] [Abstract][Full Text] [Related]
60. Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.
Lazarus HM; Blumer JL; Yanovich S; Schlamm H; Romero A
J Clin Pharmacol; 2002 Apr; 42(4):395-402. PubMed ID: 11936564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
